The effect of the new oral hypoglycemic agent A-4166 on glucose turnover in the high fat diet-induced and/or in the hereditary insulin resistance of rats

Archives of Physiology and Biochemistry

Volumn 106, Issue 4, 1998, Pages 325-332

  Klimeš, Iwar ^a   Mitkova A ^a   Gasperikova D ^a   Ukropec, J ^a   Liska B ^a   Bohov, P ^a   Stanek, J ^b   Sebokova E ^a  

^a INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^b Inst of Postgrad Medical Education   (Slovakia)

Author keywords

A 4166; High fat diet; Hypoglycemic agent; Insulin resistance

Indexed keywords

DEOXYGLUCOSE; NATEGLINIDE; PHENYLALANINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENETIC DISORDER; GLUCONEOGENESIS; GLUCOSE INFUSION; GLUCOSE METABOLISM; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; LIPID DIET; MALE; RAT; SKELETAL MUSCLE;

ANIMALS; BODY WEIGHT; CYCLOHEXANES; DEOXYGLUCOSE; DIETARY FATS; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; PHENYLALANINE; PHOSPHORYLATION; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0032467529     PISSN: 13813455     EISSN: None     Source Type: Journal    
DOI: 10.1076/apab.106.4.325.4370     Document Type: Article

References (20)

1. Argoud GM, Schade DS, Eaton RP (1987): Insulin suppresses its own secretion in vivo. Diabetes 36: 959-962.
2. DeFronzo RA, Bonadonna RC, Ferrannini E (1997): Pathogenesis of NIDDM. In: Alberti KGMM, Zimmer P, DeFronzo RA, eds., Internat Textbook of Diabetes Mellitus, J. Wiley & Sons, Chichester, UK, pp. 635-712.
3. Dunning BE (1997): New non-sulfonylurea secretagogues. Exp Opin Invest Drugs 6: 1041-1048.
4. Fujita T, Sugiyama Y, Taketomi S, Sohda T, Kawamatsu Y, Iwatsuka H, Suzuoki Z (1983): Reduction of insulin resistance in obese and/or diabetic animals by 5-:4-(1-methylcyclohexylmethoxy)benzyl:-thiozolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent. Diabetes 32: 804-810.
5. 2+ influx. Endocrinology 134: 1395-1400.
6. Ikenoue T, Akiyoshi M, Fujitani S, Okazaki K, Kondo N, Maki T (1997): Hypoglycemic and insulinotropic effect of a novel oral antidiabetic agent, (-)-N-(trans-4-isopropylcyclohexane-carbonyl)-D-phenylalanine (A-4166). Brit J Pharmacol 120: 137-145
7. Imatake M, Ebihara S, Takiguchi K, Uchida R, Ogihara N, Kikuchi M (1995): Reduction of postprandial hyperglycemia by A4166 is associated with non-hepatic glucose uptake. Diabetologia 38 (Suppl 1): 750 (Abstract)
8. James DE, Burleigh KM, Kraegen EW (1985): Time dependence of insulin action in muscle and adipose tissue in the rat in vivo. An increasing response in adipose tissue with time. Diabetes 34: 1049-1054.
9. Klimeš I, Nagulesparan M, Vasquez B, Hideki H, Unger RH (1984): Normal insulin sensitivity of the islets of Langerhans in obese subjects with resistance to its glucoregulatory actions. Diabetes 33: 305-310.
10. Klimeš I, Vrána A, Kuneš J, Šeböková E, Dobešová Z, Štolba P, Zicha J (1995): Hereditary hypertriglyceridemic rat: A new animal model of metabolic alterations in hypertension. Blood Pressure 4: 137-142.
11. Klimeš I, Šeböková E, Gašperíková D, Mitková A, Kuklová S, Bohov P, Stanek J (1998): A search for extrapancreatic effects of new oral hypoglycemic agent A-4166 in rats: Oral glucose tolerance tests in normal and insulin resistant rats. Endocrin Regul 32: 115-124.
12. Koopmans SJ, Maassen JA, Radder JK, Frölich M, Krans HMJ (1992): In vivo insulin responsiveness for glucose uptake at eu- & hyperglycemic levels in diabetic rats. Biochim Biophys Acta 1115: 230-2138.
13. Kraegen EW, James DE, Jenkins AB, Chisholm DJ (1985): Dose response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol 248: E353-E362.
14. Kraegen EW, James DE, Jenkins AB, Chisholm DJ, Storlien LH (1989): A potent in vivo effect of ciglitazone on muscle insulin resistance induced by high fat feeding of rats. Metabolism 38: 1089-1093.
15. Oakes ND, Cooney GJ, Camilleri S, Chisholm DJ, Kraegen EW (1997): Mechanisms of liver and muscle insulin resistance induced by chronic high fat feeding. Diabetes 46: 1768-1774.
16. Sato J, Nishikawa M, Shinkai H, Sukegawa E (1991): Possibility of ideal blood glucose control by a new oral hypoglycemic agent, N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (A-4166), and its stimulatory effect on insulin secretion in animals. Diabetes Res Clin Pract 12: 53-60.
17. Shinkai H, Sato Y (1990): Hypoglycemic action of phenylalanine derivatives. In: Bailey CJ, Flatt PR, eds., New Antidiabetic Drugs, Smith-Gordon Ltd., London, pp. 249-254.
18. Storlien LH, Pan DA, Kriketos AD, Baur LA (1993): High fat diet-induced insulin resistance: Lessons and implications from animal studies. Ann NY Acad Sci 683: 82-90.
19. Storlien LH, Baur LA, Kriketos AD, Pan DA, Cooney GJ, Jenkins AB, Calvert GD, Campbell LV (1996): Dietary fats and insulin action. Diabetologia 39: 621-631.
20. Vrána A, Kazdová L (1990): The hereditary hypertriglyceridemic nonobese rat: An experimental model of human hypertriglyceridemia. Transpl Proc 22: 2579.